Carnegie acted as joint bookrunner and manager in connection with the NOK 130 million private placement in Oncoinvent ASA.
Oncoinvent ASA is a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers.
Carnegie acted as joint bookrunner and manager in connection with the NOK 130 million private placement in Oncoinvent ASA.
Oncoinvent ASA is a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers.